tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

COGT Stock Latest News

Buy Rating for Cogent Biosciences Backed by Promising Clinical Trial Results and Market Potential
RatingsBuy Rating for Cogent Biosciences Backed by Promising Clinical Trial Results and Market Potential
3d ago
COGT
Cogent Biosciences Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
Cogent Biosciences Reports 2024 Financial Results and Clinical Progress
3d ago
COGT
Cogent Biosciences announces expanded results from OLE portion of SUMMIT trial
PremiumThe Fly
Cogent Biosciences announces expanded results from OLE portion of SUMMIT trial
4d ago
COGT
Cogent Biosciences price target lowered to $8 from $10 at Baird
PremiumThe Fly
Cogent Biosciences price target lowered to $8 from $10 at Baird
4d ago
COGT
Cogent Biosciences: Promising Pipeline and Financial Stability Drive Buy Rating
PremiumRatings
Cogent Biosciences: Promising Pipeline and Financial Stability Drive Buy Rating
4d ago
COGT
Cogent Biosciences: Promising Pipeline and Market Opportunities Justify Buy Rating
PremiumRatingsCogent Biosciences: Promising Pipeline and Market Opportunities Justify Buy Rating
5d ago
COGT
Cogent Biosciences sees cash runway into late 2026
Premium
The Fly
Cogent Biosciences sees cash runway into late 2026
6d ago
COGT
Cogent Biosciences reports Q4 net loss $67.9M vs. $54.4M last year
Premium
The Fly
Cogent Biosciences reports Q4 net loss $67.9M vs. $54.4M last year
6d ago
COGT
Cogent Biosciences exec buys $332K in common stock
PremiumThe Fly
Cogent Biosciences exec buys $332K in common stock
2M ago
COGT
Cogent Biosciences up 10% at $8.14 after disclosing insider buy
PremiumThe Fly
Cogent Biosciences up 10% at $8.14 after disclosing insider buy
2M ago
COGT
Cogent Biosciences price target lowered to $14 from $17 at H.C. Wainwright
PremiumThe Fly
Cogent Biosciences price target lowered to $14 from $17 at H.C. Wainwright
2M ago
COGT
Cogent Biosciences highlighted key 2025 milestones
PremiumThe Fly
Cogent Biosciences highlighted key 2025 milestones
2M ago
COGT
Cogent Biosciences downgraded to Hold from Buy at Needham
PremiumThe FlyCogent Biosciences downgraded to Hold from Buy at Needham
3M ago
COGT
Cogent Biosciences announces updates results from SUMMIT
Premium
The Fly
Cogent Biosciences announces updates results from SUMMIT
3M ago
COGT
Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial
Premium
The Fly
Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial
3M ago
COGT
Cogent Biosciences price target raised to $21 from $19 at JPMorgan
PremiumThe Fly
Cogent Biosciences price target raised to $21 from $19 at JPMorgan
4M ago
COGT
Cogent Biosciences Reports Progress in Clinical Trials and Financial Standing
PremiumCompany Announcements
Cogent Biosciences Reports Progress in Clinical Trials and Financial Standing
4M ago
COGT
Cogent Biosciences reports Q3 EPS (64c), consensus (57c)
PremiumThe Fly
Cogent Biosciences reports Q3 EPS (64c), consensus (57c)
4M ago
COGT
COGT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
COGT Upcoming Earnings Report: What to Expect?
4M ago
COGT
Cogent selloff on ‘old news’ is ‘unwarranted,’ says Citi
PremiumThe FlyCogent selloff on ‘old news’ is ‘unwarranted,’ says Citi
4M ago
BPMC
COGT
Cogent data has positive read-through to Blueprint, says Barclays
Premium
The Fly
Cogent data has positive read-through to Blueprint, says Barclays
4M ago
BPMC
COGT
Cogent Biosciences down after bezuclastinib abstract released
Premium
The Fly
Cogent Biosciences down after bezuclastinib abstract released
4M ago
COGT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >